Journal ArticleDOI
Sarcoidosis in America. Analysis Based on Health Care Use.
Robert P. Baughman,Shelli Field,Ulrich Costabel,Ronald G. Crystal,Daniel A. Culver,Marjolein Drent,Marc A. Judson,Gerhard Wolff +7 more
Reads0
Chats0
TLDR
For patients 18 years of age and older enrolled in a U.S. national administrative database, sarcoidosis was more common among African Americans, but it was reported for all four of the major ethnic groups studied.Abstract:
Rationale: There have been no recent comprehensive studies of the epidemiology of sarcoidosis in the United States. Changes in health care use have made available access to data on large numbers of patients with sarcoidosis.Objectives: To use a U.S. national health care database to gather data on patients with sarcoidosis identified over a 3-year period who were 18 years of age and older, and to determine health care costs for these patients.Methods: The Optum health care database was queried for a 3-year period (2010–2013). This database includes approximately 15% of U.S. residents. The incidence rate of sarcoidosis was calculated for new cases identified in each year. Calculation of prevalence was based on any patient with sarcoidosis seen during the year. Incidence and prevalence rates are reported per 100,000 patients.Measurements and Main Results: A total of 29,372 adult patients with sarcoidosis were identified. Of these, 14,700 (55%) were over 55 years of age at the time of diagnosis. The incidence...read more
Citations
More filters
Journal ArticleDOI
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris
B. Duchemann,Isabella Annesi-Maesano,Camille Jacobe de Naurois,Shreosi Sanyal,Pierre-Yves Brillet,Michel Brauner,Marianne Kambouchner,Sophie Huynh,Jean Marc Naccache,Raphael Borie,Jacques Piquet,Arsène Mekinian,Jérôme Virally,Yurdagul Uzunhan,Jacques Cadranel,Bruno Crestani,Olivier Fain,François Lhote,Robin Dhote,Nathalie Saidenberg-Kermanac’h,Paul-André Rosental,Dominique Valeyre,Hilario Nunes +22 more
TL;DR: Estimating the prevalence and incidence of interstitial lung diseases in Seine-Saint-Denis, a multi-ethnic county of Greater Paris, France, emphasises the importance of secondary ILDs, particularly CTDs-ILDs and the relatively low prevalence of IPF, and confirms that sarcoidosis is a rare disease in France.
Journal ArticleDOI
Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring
Panithaya Chareonthaitawee,Rob S. Beanlands,Wengen Chen,Sharmila Dorbala,Edward J. Miller,Venkatesh L. Murthy,David H. Birnie,Edward S. Chen,Leslie T. Cooper,Roderick Tung,Eric S. White,Salvador Borges-Neto,Marcelo F. Di Carli,Robert J. Gropler,Terrence D. Ruddy,Thomas H. Schindler,Ron Blankstein,Timothy M. Bateman,Manuel D. Cerqueira,Vasken Dilsizian,Gary V. Heller,David R. Moller,Michael T. Osborne,Mehran M. Sadeghi,Prem Soman +24 more
TL;DR: This research presents a meta-analyses of the determinants of coronary heart disease and stroke in mice and shows clear patterns of disease progression that are consistent with those seen in animals and humans.
Journal ArticleDOI
Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring
Panithaya Chareonthaitawee,Rob S. Beanlands,Wengen Chen,Sharmila Dorbala,Edward J. Miller,Venkatesh L. Murthy,David H. Birnie,Edward S. Chen,Leslie T. Cooper,Roderick Tung,Eric S. White,Salvador Borges-Neto,Marcelo F. Di Carli,Robert J. Gropler,Terrence D. Ruddy,Thomas H. Schindler,Ron Blankstein +16 more
TL;DR: Joint SNMMI–ASNC expert consensus document on the role of F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.
Journal ArticleDOI
Epidemiology of sarcoidosis: current findings and future directions:
TL;DR: This review reviews the epidemiological tools used, the incidence and prevalence of disease, mortality and cancer risk after sarcoidosis and nongenetic risk factors for sarcoids, and concludes that leveraging existing epidemiological data to conduct etiological studies aimed towards understanding and preventing disease is critical for future sar coidosis research.
Journal ArticleDOI
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
TL;DR: ILDs with a progressive-fibrosing phenotype appear to be more common in older adults and are associated with a complex network of environmental and genetic factors, and where further data are needed in comparison to the well-studied IPF indication is noted.
References
More filters
Journal ArticleDOI
Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis
Robert P. Baughman,Alvin S. Teirstein,Marc A. Judson,Milton D. Rossman,Henry Yeager,Eddy A. Bresnitz,Louis DePalo,Gary M. Hunninghake,Michael C. Iannuzzi,Carol J. Johns,Geoffrey McLennan,David R. Moller,Lee S. Newman,David L. Rabin,Cecile S. Rose,Benjamin A. Rybicki,Steven E. Weinberger,Michael L. Terrin,Genell L. Knatterud,Reuben Cherniak +19 more
TL;DR: It is concluded that the initial presentation of sarcoidosis is related to sex, race, and age.
Journal Article
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.
Gary W. Hunninghake,Ulrich Costabel,Masayuki Ando,Robert P. Baughman,Jean-François Cordier,du Bois R,A. Eklund,M Kitaichi,Lynch J,Rizzato G,Cecile S. Rose,Olof Selroos,Gianpietro Semenzato,Om P. Sharma +13 more
Journal ArticleDOI
Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization
TL;DR: The results should be more generalizable than previous studies done with select populations and should serve as a useful frame of reference for future epidemiologic research of sarcoidosis.
Journal ArticleDOI
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
Robert P. Baughman,Marjolein Drent,Mani S. Kavuru,Marc A. Judson,Ulrich Costabel,Roland M. du Bois,Carlo Albera,Martin Brutsche,Gerald S. Davis,James F. Donohue,Joachim Müller-Quernheim,Rozsa Schlenker-Herceg,Susan Flavin,Kim Hung Lo,Barry Oemar,Elliot S. Barnathan +15 more
TL;DR: The results of this Phase 2 clinical study support further evaluation of anti-TNF-alpha therapy in severe, chronic, symptomatic sarcoidosis.
Journal ArticleDOI
Sarcoidosis-related mortality in the United States from 1988 to 2007.
Jeffrey J. Swigris,Amy L. Olson,Tristan J. Huie,Evans R. Fernandez-Perez,Joshua J. Solomon,David Sprunger,Kevin K. Brown +6 more
TL;DR: From 1988-2007, sarcoidosis-related mortality rates increased significantly, particularly in non-Hispanic black females aged 55 years or older, and among young sarCOidosis decedents, those with pulmonary fibrosis or a cardiac cause contributing to death were more likely to be black than white.
Related Papers (5)
Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis
Robert P. Baughman,Alvin S. Teirstein,Marc A. Judson,Milton D. Rossman,Henry Yeager,Eddy A. Bresnitz,Louis DePalo,Gary M. Hunninghake,Michael C. Iannuzzi,Carol J. Johns,Geoffrey McLennan,David R. Moller,Lee S. Newman,David L. Rabin,Cecile S. Rose,Benjamin A. Rybicki,Steven E. Weinberger,Michael L. Terrin,Genell L. Knatterud,Reuben Cherniak +19 more
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool
Marc A. Judson,Ulrich Costabel,Marjolein Drent,Athol U. Wells,Lisa A. Maier,Laura L. Koth,Hidenobu Shigemitsu,Dan A. Culver,Jeffrey M. Gelfand,Dominique Valeyre,Nadera J. Sweiss,Elliott D. Crouser,Adam S. Morgenthau,Elyse E. Lower,Arata Azuma,Mami Ishihara,Shin-ichiro Morimoto,Tetsuo Tetsuo Yamaguchi,Noriharu Shijubo,Jan C. Grutters,Misha Rosenbach,Huiping Li,Paola Rottoli,Yoshikazu Inoue,Antje Prasse,Robert P. Baughman +25 more